molecular physiology and biophysics
Vanderbilt research: Better understanding of fundamental cell behavior can improve drug development
Apr. 13, 2021—Gregor Neuert has discovered that cells respond differently to acute and gradual stress. This finding will transform how cell signaling is understood and inform the drug discovery processes.
Early research shows promise for therapeutics that delay Type 2 Diabetes
Jan. 12, 2021—Discovering the mechanism behind cell behavior that is a hallmark of type 2 diabetes, Vanderbilt researchers move closer to treatments for the disease, which affects 34 million Americans.
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Oct. 27, 2020—Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases.
Vanderbilt researchers develop publicly available COVID-19 animal susceptibility prediction tool; suggests increased risk to horses
Oct. 6, 2020—All-remote collaboration results in free animal susceptibility tool to help prioritize research and closer examination of at-risk species.
Protein study may be key to treating fibrotic diseases
Jul. 30, 2020—A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently.
Get to know Vanderbilt’s residential faculty: Professor Alyssa Hasty
Jul. 17, 2020—As the new academic year gets underway, Vanderbilt’s faculty heads of house are revealing some things about themselves in this special portrait series. Get to know Alyssa Hasty, Cornelius Vanderbilt Chair in Molecular Physiology and Biophysics and faculty head of Murray House.
Insights on diabetic retinopathy
Jan. 23, 2020—A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.
Study reveals mysteries of critical brain receptor complex
Dec. 5, 2019—Poorly functioning AMPARs have been linked to a wide range of neurological and psychiatric disorders including seizures, Alzheimer’s disease, major depression and autism spectrum disorder. Understanding how AMPARs are formed and operate is essential for the rational design of pharmacological compounds that, by tuning AMPAR activity up or down, could improve treatment of these conditions.
New faculty Nancy Carrasco: From one side of the membrane to the other
Sep. 29, 2019—Nancy Carrasco, new chair of the Department of Molecular Physiology and Biophysics and originally from Mexico City, knows how enriching an experience living abroad can be.
Madhur receives Presidential Early Career Award
Jul. 18, 2019—Meena Madhur, MD, PhD, has received a Presidential Early Career Award for Scientists and Engineers.
Study details regulation of a multi-drug transporter
May. 30, 2019—Vanderbilt University researchers have discovered how a protein pump distinguishes between chemicals that it will expel from a cell and inhibitors that block its action. The new findings could guide the development of more efficient inhibitors to prevent cancer cell resistance to chemotherapy.
Shaping reward circuits
May. 18, 2018—Using techniques to control and monitor the activities of individual neurons, Vanderbilt investigators are probing the brain’s reward circuitry.